2020 | One world, one pandemic, many guidelines: management of liver diseases during COVID-19
| GUT |
2021 | One-Year Change in the H 2 FPEF Score After Catheter Ablation of Atrial Fibrillation in Patients With a Normal Left Ventricular Systolic Function
| FRONTIERS IN CARDIOVASCULAR MEDICINE |
2020 | One-year clinical outcomes of coronary chronic total occlusion intervention in patients with acute coronary syndrome versus stable angina: from the Korean chronic total occlusion registry | CORONARY ARTERY DISEASE |
2019 | One-year clinical outcomes of ticagrelor compared with clopidogrel after percutaneous coronary intervention in patients with acute myocardial infarction: From Korean Health Insurance Review and Assessment Data
| JOURNAL OF CARDIOLOGY |
2020 | One-year efficacy and safety of everolimus-eluting bioresorbable scaffolds in the setting of acute myocardial infarction
| PLOS ONE |
2004 | Onset of analgesia and analgesic efficacy of tramadol/acetaminophen and codeine/acetaminophen/ibuprofen in acute postoperative pain: A single-center, single-dose, randomized, active-controlled, parallel-group study in a dental surgery pain model | CLINICAL THERAPEUTICS |
2008 | OPCML is a broad tumor suppressor for multiple carcinomas and lymphomas with frequently epigenetic inactivation
| PLOS ONE |
2022 | Open-label, multi-center, phase II study of adjuvant pemetrexed plus cisplatin for completely resected stage IB to IIIA adenocarcinoma of the lung: APICAL trial
| TRANSLATIONAL LUNG CANCER RESEARCH |
2017 | Open-Label, Multicenter, Phase II Study of Ceritinib in Patients With Non-Small-Cell Lung Cancer Harboring ROS1 Rearrangement. | JOURNAL OF CLINICAL ONCOLOGY |
2024 | Open-Label, Multicenter, Randomized, Biomarker-Integrated Umbrella Trial for Second-Line Treatment of Advanced Gastric Cancer: K-Umbrella Gastric Cancer Study | JOURNAL OF CLINICAL ONCOLOGY |
2020 | Open-label, phase IIa study of dabrafenib plus trametinib in East Asian patients with advanced BRAF V600-mutant cutaneous melanoma | EUROPEAN JOURNAL OF CANCER |
2021 | Open-label, single arm, multicenter phase II study of VIDL induction chemotherapy followed by upfront autologous stem cell transplantation in patients with advanced stage extranodal NK/T-cell lymphoma
| BONE MARROW TRANSPLANTATION |
2021 | Open-Label, Single-Arm, Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma
| JOURNAL OF CLINICAL ONCOLOGY |
2000 | Open-label, uncontrolled, clinical trial of barnidipine hydrochloride in Korean patients with renal parenchymal hypertension | Current Therapeutic Research, Clinical and Experimental |
2023 | Open-labeled, multicenter phase II study of prophylactic administration of pegylated granulocyte colony-stimulating factor in relapsed or refractory multiple myeloma who received pomalidomide-based regimens (KMM170)
| FRONTIERS IN ONCOLOGY |
2022 | Opening opportunities for women in respiratory medicine: Letter from Korea
| RESPIROLOGY |
2022 | Operational Definition Identifying Osteoporotic Vertebral Fractures in the Claims Database
| JOURNAL OF KOREAN MEDICAL SCIENCE |
2012 | Optical coherence tomographic comparison of neointimal coverage between sirolimus- and resolute zotarolimus-eluting stents at 9 months after stent implantation | INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING |
2015 | Optical coherence tomographic observation of in-stent neoatherosclerosis in lesions with more than 50% neointimal area stenosis after second-generation drug-eluting stent implantation | CIRCULATION-CARDIOVASCULAR INTERVENTIONS |
2014 | Optical coherence tomographic observation of morphological features of neointimal tissue after drug-eluting stent implantation.
| YONSEI MEDICAL JOURNAL |